Chemed vs Privia Health Group
Chemed is the larger business, with $2.53bn of revenue in fiscal 2025 against $2.12bn for Privia Health Group (1.2 times as much). Privia Health Group grew faster (22.3% against 4.1%). Chemed kept more of each dollar of sales as profit: a net margin of 10.5% against 1.1%.
| Latest fiscal year | ChemedCHE, 2025 | Privia Health GroupPRVA, 2025 |
|---|---|---|
| Revenue | $2.53bn | $2.12bn |
| Revenue growth | 4.1% | 22.3% |
| Net income | $265m | $22.9m |
| Operating margin | 13.4% | — |
| Net margin | 10.5% | 1.1% |
| Return on equity | 25.3% | 3.3% |
| Free cash flow | $325m | $163m |
| Cash | $74.5m | $480m |
| Total debt | $0 | $0 |
| Debt to equity | 0.0% | — |
| Dividend per share | $2.20 | — |
| Dividend yield | 0.5% | — |
| Share buybacks | $432m | — |
| Employees | 15,811 | 1,226 |
| Market value | $7.03bn | $2.71bn |
| Price vs our value range | Within our value range | Within our value range |
| Moat score | 68 (Moderate) | 21 (Weak) |
| Insider trades, 12 months | 0 buys, 13 sales | 0 buys, 40 sales |